VeriMomIst tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate in der Schwangerschaft sicher?
No harmonised CLP classification, no SCCS or CIR safety assessment, and no peer‑reviewed reproductive or developmental studies located for this CAS (934368-60-2). Manufacturer/product literature (DSM Syn‑HYCAN) describes it as a tripeptide cosmetic active; regulatory/toxicology databases (EPA CompTox, supplier pages) list identity but provide no reproductive hazard. In absence of authoritative evidence of reproductive toxicity, default score is 0. Sources: DSM product sheet, EPA CompTox, lack of entries in SCCS/CIR/ECHA Annex VI.
Pregnancy-safe products containing tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate
Related ingredients
Frequently asked questions
- Ist tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate in der Schwangerschaft sicher?
- No harmonised CLP classification, no SCCS or CIR safety assessment, and no peer‑reviewed reproductive or developmental studies located for this CAS (934368-60-2). Manufacturer/product literature (DSM Syn‑HYCAN) describes it as a tripeptide cosmetic active; regulatory/toxicology databases (EPA CompTox, supplier pages) list identity but provide no reproductive hazard. In absence of authoritative evidence of reproductive toxicity, default score is 0. Sources: DSM product sheet, EPA CompTox, lack of entries in SCCS/CIR/ECHA Annex VI.
- Ist tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate während des Stillens sicher?
- No data located showing lactational transfer, mammary toxicity, or reproductive system effects. No SCCS/CIR opinion or harmonised hazard for this ingredient. Therefore default hazard/mechanism = 0 and exposure from topical cosmetic use is considered negligible based on peptide structure and marketed aqueous/glycerin formulations. Sources: DSM Syn‑HYCAN product literature, EPA CompTox, PubMed search (no relevant studies found).
- Ist tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate sicher für Babyhaut?
- No infant-specific toxicity or dermal absorption studies were found. Peptide active (high MW, water‑soluble glycerin formulations) suggests low systemic absorption in adults (adult e=0). Per scoring rules, because adult absorption is not demonstrably zero and infant skin has higher permeability, exposure for 0–3 yr is conservatively increased by +1 to e=1. No data were found to increase hazard (h) or mechanism (m) scores for infants. Sources: DSM Syn‑HYCAN brochure, EPA CompTox, EWG listing noting concern but not providing reproductive/infant data.
- Wie bewertet VeriMom tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate?
- VeriMom bewertet tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate mit 100/100 (keine bekannten Risiken) basierend auf EU CosIng, ECHA-Klassifizierungen und PubMed-Studien.
- Was sind schwangerschaftssichere Alternativen zu tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate?
- Siehe unsere kuratierte Liste der schwangerschaftssicheren Alternativen zu tetradecyl aminobutyroylvalylaminobutyric urea trifluoroacetate basierend auf ähnlicher Funktion.
Prüfe jede Zutatenliste in 2 Sekunden
Lade VeriMom kostenlos — scanne jedes Produkt und sieh sofort die Schwangerschafts-Sicherheitsbewertung.
Medizinischer Haftungsausschluss
Diese Informationen dienen ausschließlich Bildungszwecken und stellen keine medizinische Beratung dar. Sicherheitsbewertungen basieren auf öffentlich zugänglichen Daten und spiegeln möglicherweise nicht alle Risiken wider. Konsultieren Sie immer Ihren Arzt, bevor Sie ein Produkt während der Schwangerschaft oder Stillzeit verwenden.